After Mylan raised the price of its EpiPen by 400 percent, sparking a wave of controversy, the company now says it will offer a savings card worth $300 to users, effectively cutting the drug price in half.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
























